ReNeuron Group (FRA:RQE1) EBIT per Share : €-0.12 (TTM As of Sep. 2023)

View and export this data going back to 2007. Start your Free Trial

What is ReNeuron Group EBIT per Share?

ReNeuron Group's EBIT per Share for the six months ended in Sep. 2023 was €-0.07. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 was €-0.12.

During the past 3 years, the average EBIT per Share Growth Rate was 35.00% per year. During the past 5 years, the average EBIT per Share Growth Rate was 28.70% per year. During the past 10 years, the average EBIT per Share Growth Rate was 13.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for ReNeuron Group's EBIT per Share or its related term are showing as below:

FRA:RQE1' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -16.7 Med: 18.6 Max: 40.3
Current: 35

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of ReNeuron Group was 40.30% per year. The lowest was -16.70% per year. And the median was 18.60% per year.

FRA:RQE1's 3-Year EBIT Growth Rate is ranked better than
84.44% of 1298 companies
in the Biotechnology industry
Industry Median: 3.4 vs FRA:RQE1: 35.00

ReNeuron Group's EBIT for the six months ended in Sep. 2023 was €-3.73 Mil.

ReNeuron Group EBIT per Share Historical Data

The historical data trend for ReNeuron Group's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReNeuron Group EBIT per Share Chart

ReNeuron Group Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EBIT per Share

Get a 7-Day Free Trial

-0.61

-0.49

-0.40

-0.23

-0.13

ReNeuron Group Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EBIT per Share	Get a 7-Day Free Trial															-0.12	-0.11	-0.08	-0.06	-0.07

ReNeuron Group EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

ReNeuron Group's EBIT per Share for the fiscal year that ended in Mar. 2023 is calculated as

	EBIT per Share		(A: Mar. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-7.523	/	57.126
=	-0.13

ReNeuron Group's EBIT per Share for the quarter that ended in Sep. 2023 is calculated as

	EBIT per Share		(Q: Sep. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-3.734	/	57.174
=	-0.07

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.12

ReNeuron Group (FRA:RQE1) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

ReNeuron Group EBIT per Share Related Terms

Thank you for viewing the detailed overview of ReNeuron Group's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

ReNeuron Group (FRA:RQE1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (FRA:RQE1) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

RNUGF:USA RENE.GB:UK RENE:UK

Address

Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY

Website

https://www.reneuron.com

ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.

ReNeuron Group (FRA:RQE1) Headlines

No Headlines